Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT05508763
Personalised Therapeutics @LUMC
Sponsor: Leiden University Medical Center
View on ClinicalTrials.gov
Summary
In PT@LUMC 2000 patients will be randomized between a PGx-guided dosing group and a standard of care group. The patients will be followed for one year in which they will be asked to report adverse drug reactions at one, three, six and twelve months.
Official title: Personalised Therapeutics @ Leiden University Medical Center
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
2000
Start Date
2022-12-01
Completion Date
2026-10
Last Updated
2025-03-24
Healthy Volunteers
No
Conditions
Interventions
GENETIC
Genetic test for 14 pharmacogenes
Genotyping with the Global Diversity Array-8 v1.0 BeadChip with enhanced PGx
Locations (1)
Leiden University Medical Center
Leiden, South Holland, Netherlands